Lehrstuhl für Haut- und Geschlechtskrankheiten

Ein Lues-ähnliches Bild verursacht durch PVL-positive Staphylokokken (2023) Busch D, Schliep S, Berking C, Bosch-Voskens C Journal article DeepNAPSI multi-reader nail psoriasis prediction using deep learning (2023) Folle L, Fenzl P, Fagni F, Thies M, Christlein V, Meder C, Simon D, et al. Book chapter / Article in edited volumes Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment (2023) Petzold A, Steeb T, Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article, Review article Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas (2023) Koch E, Erdmann M, Berking C, Kiesewetter F, Kramer R, Schliep S, Heppt M Journal article CD83 acts as immediate early response gene in activated macrophages and exhibits specific intracellular trafficking properties (2023) Langguth P, Peckert K, Beck P, Kuhnt C, Draßner C, Deinzer A, Steinkasserer A, Wild A Journal article Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany (2023) Weisshaar E, Bentz P, Haufe E, Heinrich L, Apfelbacher C, Heratizadeh A, Abraham S, et al. Journal article Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training (2023) Kaiser I, Pfahlberg AB, Mathes S, Uter W, Diehl K, Steeb T, Heppt M, Gefeller O Journal article VEXAS syndrome mimicking lupus-like disease (2023) Valor-Mendez L, Sticherling M, Zeschick M, Atreya R, Schmidt D, Waldfahrer F, Saake M, et al. Journal article, Letter CD83 expressed by macrophages is an important immune checkpoint molecule for the resolution of inflammation (2023) Peckert-Maier K, Langguth P, Strack A, Stich L, Mühl-Zürbes P, Kuhnt C, Drassner C, et al. Journal article Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors (2023) Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, et al. Journal article